Zhamilya Zhankina

Ms. Zhamilya Zhankina

Biology, Friedrich-AlexanderUniversity Erlangen-Nürnberg (FAU), Erlangen, Bavaria, Germany
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Almagul KurmanovaAlmagul Kurmanova
Almagul Kurmanova
YAYeldar Ashirbekov
Yeldar Ashirbekov
GKGaukhar Kurmanova
Gaukhar Kurmanova
NMNagima Mamedalieva¹
Nagima Mamedalieva¹
GAGaini Anartayeva
Gaini Anartayeva
ZZZhamilya Zhankina
Zhamilya Zhankina
Reproductive disorders are common events in modern reproductive medicine, occurring both in spontaneous and assisted pregnancies. Studies on the molecular mechanisms of implantation disorders in thin endometria, including the study of gene transcriptional activities, have shed light on the identification of the potential biological markers of endometrial receptivity. Background/Objectives: The goal of this study was to reveal the significantly dysregulated selected gene expressions between RIF and RPL patients with thin endometria. Methods: Endometrial samples were collected from RIF patients (n = 20) and RPL patients (n = 19) during the implantation window days (LH + 7—LH + 10) of their natural menstrual cycles. Ten genes were chosen as the target genes regarding their possible relations with the implantation process. The total RNA was purified and reverse-transcribed, and gene expressions were quantified by RT-PCR. Results: The expressions of the IL-15, INFG, and HPRT1 genes were significantly decreased in the RIF patients with thin endometria compared to the RPL patients (log2 fold change = 0.92, p = 0.023 for IL-15; log2 fold change = 1.24, p = 0.046 for INFG; and log2 fold change = 0.579, p = 0.046 for HPRT1). There were no significant differences in the expressions of the CXCL8, CXCL1, MMP10, C4BPA, TNC, VEGFB, and HAND2 genes between the groups. Conclusions: Decreased expressions of the IL-15, INFG, and HPRT1 genes were found in patients with RIF with thin endometria compared to the endometria of women with RPL. This has practical significance for clinicians for the differentiated prescription of immunomodulatory therapy in patients undergoing ART programs.

6 April 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
AAAlmira Akparova
Almira Akparova
GKGaukhar Kurmanova
Gaukhar Kurmanova
GOGulzhakhan Omarova
Gulzhakhan Omarova
Almagul KurmanovaAlmagul Kurmanova
Almagul Kurmanova
MZMoldir Doctor Moldir Zhunisbek
Moldir Doctor Moldir Zhunisbek
ASAdemi Samadin
Ademi Samadin
Mucins are highly glycosylated proteins that form the structural basis of mucus and represent a key component of innate immunity at mucosal surfaces, particularly in the respiratory tract. Beyond their mechanical barrier function, mucins actively participate in pathogen trapping, regulation of mucociliary clearance, modulation of inflammatory responses, and maintenance of epithelial homeostasis. Dysregulation of mucin synthesis, composition, or transport contributes to mucus hypersecretion, impaired airway clearance, and chronic inflammation in respiratory diseases such as asthma, chronic obstructive pulmonary disease, and cystic fibrosis. This review summarizes current insights into mucin biology, including their biosynthesis, structure, classification, and regulation, with emphasis on the gel-forming mucins MUC5AC and MUC5B. The role of mucins in mechanical protection, host–pathogen interactions, control of inflammation, and coordination of innate immune responses is reviewed. Attention is given to the interplay between mucins, immune cells, and microbial communities in maintaining airway barrier integrity. The article further examines mucoactive therapeutic strategies aimed at restoring mucus barrier function. Expectorants, mucolytics, mucoregulators, and mucokinetic agents are reviewed with respect to their mechanisms of action and clinical relevance. Established drugs, including N-acetylcysteine, carbocysteine, dornase alfa, ambroxol, and hypertonic solutions, are considered alongside emerging molecular targets such as NF-κB-dependent regulation of mucin expression, calcium-activated chloride channels, MARCKS-mediated mucin exocytosis, purinergic signaling pathways, and NO/cGMP signaling. Non-pharmacological approaches, including airway clearance techniques and respiratory rehabilitation, are covered concisely. Conclusions: Overall, this review highlights mucins as dynamic regulators of innate immunity and underscores the need for mechanism-based, personalized mucoactive therapies to improve outcomes in chronic inflammatory airway diseases.

14 August 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
Almagul KurmanovaAlmagul Kurmanova
Almagul Kurmanova
YAYeldar Ashirbekov
Yeldar Ashirbekov
GKGaukhar Kurmanova
Gaukhar Kurmanova
NMNagima Mamedalieva¹
Nagima Mamedalieva¹
GAGaini Anartayeva
Gaini Anartayeva
ZZZhamilya Zhankina
Zhamilya Zhankina
Reproductive disorders are a common event in modern reproductive medicine, occurring both in spontaneous and assisted pregnancies. Studies of the molecular mechanisms of implantation disorders in thin endometrium, including the study of gene transcriptional activity, have shed light on the identification of potential biological markers of endometrial receptivity. Background/Objectives: to reveal significantly dysregulated selected genes expression between RIF and RPL patients with thin endometrium. Methods: Endometrial samples were collected in the implantation window days (LH+7 – LH+10) of the natural menstrual cycle from RIF patients (n=20) and RPL patients (n=19). Ten genes were chosen as target genes regarding their possible relations with the implantation process. Total RNA was purified, reverse-transcribed; gene expression was quantified by RT-PCR. Results: The expression of the IL-15, INFG and HPRT1 genes were significantly decreased in RIF with thin endometrium patients compared to the RPL patients (log2 fold change=0.92, p=0.023 for IL-15, log2 fold change=1.24, p=0.046 for INFG, and log2 fold change=0.579, p=0.046 for HPRT1). There were not significant differences in expression of CXCL8, CXCL1, MMP10, C4BPA, TNC, VEGFB and HAND2 genes between groups. Conclusions: decreased expression of IL-15, INFG and HPRT1 genes was found in patients with RIF with thin endometrium compared to the endometrium of women with RPL. This has practical significance for clinicians for differentiated prescription of immunomodulatory therapy in patients undergoing ART programs.

12 July 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
MKMadina Khalmirzaeva
Madina Khalmirzaeva
GOGulzhakhan Omarova
Gulzhakhan Omarova
Almagul KurmanovaAlmagul Kurmanova
Almagul Kurmanova
GKGaukhar Kurmanova
Gaukhar Kurmanova
GAGaini Anartayeva
Gaini Anartayeva
ADAlfiya Dzheksembekova
Alfiya Dzheksembekova
Background: Recurrent pregnancy loss (RPL) is frequently linked to antiphospholipid antibodies, yet many affected women are seronegative for the classical (Sydney) criteria antibodies. In a previously characterized cohort, an extended antiphospholipid antibody panel was positive in 79% of women with RPL, with the strongest associations for antibodies against prothrombin, annexin V and β2-glycoprotein I. Whether this association reflects molecular endometrial dysfunction was unclear. Objective: To examine endometrial expression of ten decidualization- and inflammation-related genes in women with RPL, stratified by APL status, focusing on the dominant antibody specificity: anti-β2-glycoprotein I. Methods: Thirty-nine women with RPL (≥2 losses), a subsample of a published 100-patient cohort, underwent mid-luteal Pipelle endometrial biopsy followed by RT-PCR for C4BPA, CXCL1, HAND2, HPRT1, IFNG, IL15, IL8 (CXCL8), MMP10, TNC and VEGFB. Antibodies were measured by antiphospholipid 10 Dot line immunoblot (Generic Assays, Germany). The analysis used Mann–Whitney U, Fisher’s exact test, Benjamini–Hochberg correction and ROC analysis. Results: Antibody prevalence in the subsample matched the parent cohort (Pearson r = 0.999). Of ten transcripts, only HAND2 showed a nominally significant reduction in APL+ women (median ΔCt −2.04 vs. −1.30; p = 0.037; rank-biserial r = −0.47); this signal did not survive Benjamini–Hochberg correction (q = 0.372). The signal was specific to anti-β2GPI (p = 0.064; AUC 0.700), not to annexin V or prothrombin. A cut-off of HAND2 ΔCt ≤ −1.60 identified APL+ status with 73% sensitivity, 78% specificity and OR 9.62 (95% CI 1.64–56.4; p = 0.015). HAND2 clustered with IL15 (ρ = 0.65) and VEGFB (ρ = 0.70). Conclusions: Anti-β2-glycoprotein I antibodies, the dominant APL specificity in RPL, are associated with reduced endometrial HAND2 expression. This exploratory data outline a candidate molecular pathway linking extended antiphospholipid serology to impaired endometrial receptivity.

24 September 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
MMMaira Melis
Maira Melis
GKGaukhar Kurmanova
Gaukhar Kurmanova
AAAlmira Akparova
Almira Akparova
NZNazima Zarubekova
Nazima Zarubekova
LALaura Alikulova
Laura Alikulova
ZZZhamilya Zhankina
Zhamilya Zhankina
Background: Effective empirical therapy and antimicrobial stewardship rely on up-to-date local data on respiratory pathogens and antimicrobial resistance trends. In Kazakhstan, contemporary microbiological surveillance remains limited, particularly for hospitalized patients with chronic pulmonary disease (COPD) and pneumonia. This study aimed to characterize the microbial profiles and antimicrobial susceptibility patterns in respiratory specimens from these patient groups in Almaty, Kazakhstan. Methods: This retrospective observational study included adult patients hospitalized at a tertiary referral center between January 2024 and December 2025. Respiratory specimens (sputum and bronchoalveolar lavage) underwent bacterial culture, species identification using MALDI-TOF MS, and antimicrobial susceptibility testing via EU-CAST disk diffusion. Susceptibility was interpreted according to EUCAST categories (S, I, R). Group comparisons were performed using Pearson’s chi-square or Fisher’s exact test with Benjamini-Hochberg correction. Results: Among 713 patients (255 COPD exacerbation; 458 pneumonia), Streptococcus pyogenes was the most frequently isolated organism in both groups, followed by viridans group streptococci (VGS) and Streptococcus pneumoniae. Gram-negative isolates included most frequently Klebsiella pneumoniae, Klebsiella aerogenes, and Pseudomonas aeruginosa. After correction for multiple testing, bacterial distribution did not differ significantly between COPD and pneumonia. Streptococcal isolates demonstrated consistently high susceptibility to β-lactams, while susceptibility to macrolides, clindamycin, and doxycycline was lower. Gram-negative organisms demonstrated more variable resistance profiles. MDR phe-notypes were common among K. pneumoniae (16.7% COPD; 31.0% pneumonia) and P. aeruginosa (22.2% COPD; 17.9% pneumonia), with no significant between group dif-ferences. Conclusions: COPD exacerbation and pneumonia patients showed broadly similar bacterial profiles, whereas antimicrobial susceptibility varied substantially across species. High β-lactam activity against streptococci contrasted with complex resistance patterns and notable MDR/XDR phenotypes among Gram-negative organisms. These findings highlight the importance of ongoing institution-specific surveillance to support antimicrobial stewardship and guide empirical treatment decisions.